10 results
6-K
EX-99.1
STVN
Stevanato Group Spa
28 Sep 23
Current report (foreign)
9:31am
tenure as Chief Executive Officer. Prior to management in multinational industrial companies and joined Stevanato Group in 2018 as Chief Operating … the region. and analytical projects, and other activities supporting the Group’s throughout his tenure, including Corporate General Manger vision. and Chief
20-F/A
2021 FY
STVN
Stevanato Group Spa
5 Apr 22
Annual report (foreign) (amended)
7:14am
the company in 1997. Prior to his tenure at Amgen, Mr. Balachandran held leadership positions at Copley Pharmaceuticals, now a part of Teva
20-F
2021 FY
STVN
Stevanato Group Spa
8 Mar 22
Annual report (foreign)
6:50am
and retired as an Executive Vice President in January 2017, having served in various management positions since joining the company in 1997. Prior to his tenure
424B4
STVN
Stevanato Group Spa
16 Jul 21
Prospectus supplement with pricing info
2:18pm
President in January 2017, having served in various management positions since joining the company in 1997. Prior to his tenure at Amgen, Mr
F-1/A
lp0kb
12 Jul 21
Registration statement (foreign) (amended)
7:22am
F-1/A
iwlrb4v18vcrl2bvd
7 Jul 21
Registration statement (foreign) (amended)
9:59am
F-1
7f6ce373o
21 Jun 21
Registration statement (foreign)
8:54am
DRS/A
jz4j1 6e92w5shh
30 Apr 21
Draft registration statement (amended)
12:00am
DRS
nb0569ku
22 Mar 21
Draft registration statement
12:00am
- Prev
- 1
- Next